192 related articles for article (PubMed ID: 36045537)
1. The Prognostic and Drug-targeting Value of Lymphoid Enhancer-binding Factor-1 in Hepatocellular Carcinoma.
Guo R; Dai H; Liu F; Liu M; Li X; Li T; Liao J; Chen ZS; Liu Y; Fang S
Recent Pat Anticancer Drug Discov; 2022; 18(2):211-223. PubMed ID: 36045537
[TBL] [Abstract][Full Text] [Related]
2. CK2B is a Prognostic Biomarker and a Potential Drug Target for Hepatocellular Carcinoma.
Dai H; Liu M; Pan Y; Li T; Pan Y; Chen Z; Li J; Liu Y; Fang S
Recent Pat Anticancer Drug Discov; 2023 Sep; ():. PubMed ID: 37779404
[TBL] [Abstract][Full Text] [Related]
3. Identifying the predictive role and the related drugs of oxidative stress genes in the hepatocellular carcinoma.
Nie G; Zhu X; Zhang H; Wang H; Yan J; Li X
Cancer Rep (Hoboken); 2024 Apr; 7(4):e1978. PubMed ID: 38599581
[TBL] [Abstract][Full Text] [Related]
4. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
5. A novel prognostic models for identifying the risk of hepatocellular carcinoma based on epithelial-mesenchymal transition-associated genes.
Xiong C; Wang G; Bai D
Bioengineered; 2020 Dec; 11(1):1034-1046. PubMed ID: 32951492
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
[No Abstract] [Full Text] [Related]
7. Overexpressed PAQR4 predicts poor overall survival and construction of a prognostic nomogram based on PAQR family for hepatocellular carcinoma.
Qu C; Ma T; Yan X; Li X; Li Y
Math Biosci Eng; 2022 Jan; 19(3):3069-3090. PubMed ID: 35240821
[TBL] [Abstract][Full Text] [Related]
8. Identification and validation of a prognostic-related mutant gene
Song Z; Song X; Li H; Cheng Z; Mo Z; Yang X
Front Immunol; 2023; 14():1236995. PubMed ID: 38022557
[TBL] [Abstract][Full Text] [Related]
9. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
10. Targeting LEF1-mediated epithelial-mesenchymal transition reverses lenvatinib resistance in hepatocellular carcinoma.
Li X; Su H; Tang W; Shu S; Zhao L; Sun J; Fan H
Invest New Drugs; 2024 Apr; 42(2):185-195. PubMed ID: 38372948
[TBL] [Abstract][Full Text] [Related]
11. A prognostic model for hepatocellular carcinoma based on apoptosis-related genes.
Liu R; Wang G; Zhang C; Bai D
World J Surg Oncol; 2021 Mar; 19(1):70. PubMed ID: 33712023
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of EWSR1 (Ewing sarcoma breakpoint region 1/EWS RNA binding protein 1) predicts poor survival in patients with hepatocellular carcinoma.
Jiang W; Wu T; Shi X; Xu J
Bioengineered; 2021 Dec; 12(1):7941-7949. PubMed ID: 34612781
[TBL] [Abstract][Full Text] [Related]
13. [Overexpression of Nei endonuclease VIII-like protein 3 in hepatocellular carcinoma indicates increased levels of immune infiltration and an unfavorable prognosis].
Wang GN; Zhang YP; Wang MC; Han W; Zhang YC
Zhonghua Gan Zang Bing Za Zhi; 2023 Sep; 31(9):986-995. PubMed ID: 37872095
[No Abstract] [Full Text] [Related]
14. Five metastasis-related mRNAs signature predicting the survival of patients with liver hepatocellular carcinoma.
Chen C; Liu YQ; Qiu SX; Li Y; Yu NJ; Liu K; Zhong LM
BMC Cancer; 2021 Jun; 21(1):693. PubMed ID: 34116652
[TBL] [Abstract][Full Text] [Related]
15. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach.
Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824
[TBL] [Abstract][Full Text] [Related]
16. TMEM147 Correlates with Immune Infiltration and Serve as a Potential Prognostic Biomarker in Hepatocellular Carcinoma.
Cheng S; Li J; Xu M; Bao Q; Wu J; Sun P; Han B
Anal Cell Pathol (Amst); 2023; 2023():4413049. PubMed ID: 37305689
[TBL] [Abstract][Full Text] [Related]
17. Repression of WT1-Mediated LEF1 Transcription by Mangiferin Governs β-Catenin-Independent Wnt Signalling Inactivation in Hepatocellular Carcinoma.
Tan HY; Wang N; Li S; Hong M; Guo W; Man K; Cheng CS; Chen Z; Feng Y
Cell Physiol Biochem; 2018; 47(5):1819-1834. PubMed ID: 29953980
[TBL] [Abstract][Full Text] [Related]
18. Characterization of prognostic value and immunological roles of RAB22A in hepatocellular carcinoma.
Wen F; Meng F; Li X; Li Q; Liu J; Zhang R; Zhao Y; Zhang Y; Wang X; Ju S; Cui Y; Lu Z
Front Immunol; 2023; 14():1086342. PubMed ID: 36936971
[TBL] [Abstract][Full Text] [Related]
19. Identification of hepatocellular carcinoma-related genes associated with macrophage differentiation based on bioinformatics analyses.
Cao J; Zhang C; Jiang GQ; Jin SJ; Wang Q; Wang AQ; Bai DS
Bioengineered; 2021 Dec; 12(1):296-309. PubMed ID: 33380242
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Ribosomal Protein S6 Kinase A4 (RPS6KA4) Predicts a Poor Prognosis in Hepatocellular Carcinoma Patients: A Study Based on TCGA Samples.
Lu Y; Ren X; Zhou C; Chen H; Fan Y; Wang C
Comb Chem High Throughput Screen; 2022; 25(13):2165-2179. PubMed ID: 35232347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
